Research
and
Reports
As a leader in advancing IBD care, CCCure is deeply invested in research and providing the highest quality data to drive transformative outcomes. Our innovative CCCare platform plays a pivotal role in supporting research, developing innovative treatments, and working toward finding a cure for IBD.
This page is a hub for researchers, clinicians, and all interested parties to access the latest studies, reports, and findings powered by CCCure’s comprehensive data and expert insights.
Explore significant abstracts presented at prestigious international conferences including European Crohn’s and Colitis Organisation (ECCO) and Digestive Disease Week (DDW), as well as upcoming research that continues to leverage our cutting-edge platform.
Visit our CCCare page to learn more about it and how it can benefit individuals and organisations.
Articles
Reports
Krishnaprasad et al.
“Initial evaluation demonstrates CCCare is usable, secure, and valued in clinical use. It is designed to measure outcomes of clinical care, including efficacy, quality, cost, and complications for individuals, and to audit these at hospital and national level.”
View Article Here
Kaazan et al.
“CCCare is effective in supporting more complete IBD-specific data capture compared with usual medical records. It is highly acceptable to patients, especially those with reasonable IT literacy. Patient concerns about privacy and security of electronic medical records (EMRs) did not significantly affect acceptability.”
View Article Here
Barnes et al.
“CCCare can be used to examine concordance between patients’ and doctors’ judgements of disease activity. CCCare will also enable quality data on extraintestinal manifestations to be reported for incidence and prevalence and better inform their relationship to disease activity and response to various therapies in large cohorts.”
View Article Here
Lores et al.
“Integrating brief screening questionnaires into clinical management software enables proactive screening
for psychological distress and impaired QoL in people
with IBD.”
View Article Here
McNamara et al.
“This highlights the importance of technology
in facilitating communication and willingness of patient
consumers to use technology as part of their health care delivery when invited to do so.”
View Article Here
Pipicella et al.
“…widespread consumer co-design and consultation ensure vital functionality is not missed, resulting in a product meeting the needs of all consumers.”
View Article Here
Abstracts
2024
2023
2022
Pipicella et al.
Journal of Gastroenterology and Hepatology 37 (Suppl. 1) (2022) pp. 224
Australian Gastroenterology Week 2022
Available here
Pipicella et al.
Pediatric Gastroenterology, Hepatology & Nutrition 3 (Suppl. 1) (2022) pp. 145-146
6th International Symposium on Paediatric Inflammatory Bowel Disease 2022
Available here
Forbes et al.
Gastroenterology and Hepatology From Bed to Bench 16 (Suppl. 1) (2023) pp. S28-S29
New Zealand Society of Gastroenterology Annual Scientific Meeting 2022
Available here
2021
Barnes et al.
Journal of Gastroenterology and Hepatology
Australian Gastroenterology Week 2021
Available here
Pipicella et al.
Journal of Gastroenterology and Hepatology
Australian Gastroenterology Week 2021
Available here
Pipicella et al.
Gut 70 (Suppl 2) (2021) pp. A109-A109
International Digestive Disease Forum 2021
Available here
2020
Kaazan et al.
Journal of Gastroenterology and Hepatology
Australian Gastroenterology Week 2020
Available here
Dated 20 December 2022
Contact [email protected] for more information
Dated 06 January 2023
Contact [email protected] for more information
Dated 03 March 2023
Contact [email protected] for more information
Dated September 2023
Contact [email protected] for more information
Upcoming Manuscripts
Contact [email protected] for more information
Contact [email protected] for more information
McNamara et al.
Contact [email protected] for more information.
McGrory et al.
Contact [email protected] for more information.
Contact [email protected] for more information.